Vicarious Surgical reports Q1 2024 net loss of $17.0M; cash burn guidance unchanged at $50M

Vicarious Surgical Inc.

2024-Q1 EPS reported -$0.10

GAAP net loss $17.0M ($0.10/sh) vs $26.9M ($0.21) YoY; adjusted net loss $15.1M ($0.09).
Operating expenses fell 28% to $16.1M from $22.3M; R&D $10.0M, G&A $5.0M, S&M $1.1M.
Cash & investments $84.1M; Q1 cash burn $14.1M; FY 2024 cash burn guidance reaffirmed at ~$50M.
Completed spring cadaver lab; refining V1.0 system ahead of final integration in fall 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

Vicarious Surgical Inc. reported the quarter ended March 31, 2024 results: net income GAAP net loss for the first quarter was $17.0 million, equating to a net loss per share of $0.10, EPS $0.10. Guidance reaffirmed.

Period: the quarter ended March 31, 2024
Net income: GAAP net loss for the first quarter was $17.0 million, equating to a net loss per share of $0.10
EPS: $0.10
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Vicarious Surgical Reports First Quarter 2024 Financial Results

View on SEC.gov

292 earnings releases filed in the last 30 days. Browse all earnings releases →

Vicarious Surgical Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-037162

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.